Coronavirus (COVID-19) Current Therapy Market Outlook Is Being Shaped By Antibody Therapy
The Business Research Company’s COVID-19 Current Therapy Market 2022 – Opportunities And Strategies – Global Forecast To 2030
Stay updated with breaking news from Ipca Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Business Research Company’s COVID-19 Current Therapy Market 2022 – Opportunities And Strategies – Global Forecast To 2030
IPCA Ratlam unit head Dinesh Siyal informed that IPCA Laboratories invested Rs.40 crore last year under the environment head besides spending every year Rs 12 crore to Rs 14 crore for proper environment maintenance and management.
Stock markets open on a lacklustre note: Sensex up, Nifty above 16,200
/PRNewswire/ -- Coronavirus (COVID-19) current therapy market segmentation is done by drug type into antiviral, monoclonal antibodies, corticosteroid,...
The COVID therapy market includes drugs in the form of antivirals, MAbs, and more. However, the market is set to see decline in the forecast period. LONDON, March 15, 2022 /PRNewswire/